Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss…
In recent developments, the once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to injectable treatments that have driven soaring demand.…
You Missed
Kalshi Ordered to Temporarily Stop Operations in Nevada
admin
- Mart 20, 2026
- 1 views
Crypto Biz: Institutions aren’t waiting for the bottom
admin
- Mart 20, 2026
- 0 views
Google Threat Intel flags ‘Ghostblade’ crypto-stealing malware
admin
- Mart 20, 2026
- 0 views
Bitcoin price aims to hold $70K amid rising inflation concerns
admin
- Mart 20, 2026
- 0 views
